Cardinal Health, Inc. $CAH Shares Sold by Brandes Investment Partners LP

Brandes Investment Partners LP reduced its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 21.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 781,909 shares of the company’s stock after selling 208,722 shares during the period. Cardinal Health comprises approximately 1.2% of Brandes Investment Partners LP’s holdings, making the stock its 28th biggest position. Brandes Investment Partners LP’s holdings in Cardinal Health were worth $160,685,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently added to or reduced their stakes in the company. Aventura Private Wealth LLC acquired a new position in Cardinal Health during the 4th quarter worth $25,000. Palladiem LLC acquired a new position in shares of Cardinal Health in the 4th quarter valued at about $28,000. Elyxium Wealth LLC acquired a new position in shares of Cardinal Health in the 4th quarter valued at about $34,000. Barnes Dennig Private Wealth Management LLC boosted its holdings in shares of Cardinal Health by 38.7% in the 4th quarter. Barnes Dennig Private Wealth Management LLC now owns 190 shares of the company’s stock valued at $39,000 after buying an additional 53 shares during the period. Finally, JPL Wealth Management LLC acquired a new position in shares of Cardinal Health in the 3rd quarter valued at about $31,000. 87.17% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

CAH has been the subject of several research reports. Leerink Partners reaffirmed an “outperform” rating and issued a $275.00 price target on shares of Cardinal Health in a report on Monday, March 9th. JPMorgan Chase & Co. decreased their price target on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating for the company in a report on Monday, May 4th. Weiss Ratings lowered shares of Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a report on Tuesday, May 19th. Barclays lifted their price target on shares of Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a report on Tuesday, February 24th. Finally, Citigroup decreased their price target on shares of Cardinal Health from $249.00 to $245.00 and set a “buy” rating for the company in a report on Friday, May 1st. One analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, Cardinal Health presently has an average rating of “Moderate Buy” and an average target price of $246.93.

Cardinal Health Stock Up 3.8%

Shares of NYSE:CAH opened at $212.20 on Wednesday. The company has a market cap of $49.70 billion, a PE ratio of 32.45, a P/E/G ratio of 1.12 and a beta of 0.52. The company’s 50-day moving average price is $202.58 and its 200 day moving average price is $208.60. Cardinal Health, Inc. has a fifty-two week low of $137.75 and a fifty-two week high of $233.60.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating the consensus estimate of $2.79 by $0.38. The firm had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. Cardinal Health’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same period last year, the firm posted $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, equities analysts anticipate that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be given a dividend of $0.5158 per share. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date is Wednesday, July 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 1.0%. Cardinal Health’s payout ratio is presently 31.19%.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.